Certain high blood pressure medications may alter heart risk in people with HIV

Hypertension journal report

2021-04-05

(Press-News.org) DALLAS, April 5, 2021 -- When people with human immunodeficiency virus (HIV) develop high blood pressure, the type of medication chosen for their initial treatment may influence their risk of heart disease, stroke and heart failure, according to new research published today in Hypertension, an American Heart Association journal.

With current anti-retroviral medications, people with HIV are able to live longer. However, people with HIV receiving anti-retroviral therapy (ART) are more likely to develop high blood pressure (hypertension) and hypertension-related heart problems than people who do not have the virus. The current study is the first to examine how the choice of blood pressure medications influences the long-term risk of heart disease, stroke and heart failure in this population that has a higher risk of CVD.

"We suspected there could be differences in risk based on which medications providers select to treat hypertension among people with HIV due to potential interactions between blood pressure medications and some therapies used to treat the virus. Additionally, factors such as how the body handles salt, inflammation and the accelerated aging of blood vessels may affect the risk of cardiac events in people with HIV differently than people who do not have HIV, which could be influenced by which blood pressure medication is used," said the study's senior author Jordana B. Cohen, M.D., M.S.C.E., assistant professor of medicine and epidemiology in the renal-electrolyte and hypertension division in the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.

In the current study, the researchers reviewed records of 8,041 veterans with HIV (average age 53 years, 97% male, 49% Black adults) who developed high blood pressure between 2000-2018; 6,516 had never been diagnosed with heart or blood vessel problems. At baseline, of the 8,041 patients, 5,979 (74%) were on anti-retroviral medication therapy and 6,582 (82%) were prescribed single antihypertensive medication therapy: 1,025 (13%) on beta blockers, 848 (11%) on calcium channel blockers, 1,905 (24%) on ACEi/ARBs and 1,865 (23%) on diuretics. The occurrence of heart disease (heart attack, heart-related chest pain, or need for a procedure to open narrowed arteries supplying blood to the heart), stroke or heart failure over the next 6.5 years was compared among the study participants based on the different types of blood pressure medications.

Researchers found: In this study, 13% of the veterans with HIV were prescribed beta-blockers as their initial hypertension treatment. Single-medication treatment was started with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ACEi/ARBs) in 24% of patients; thiazide or similar diuretics in 23%; and calcium channel blockers (CCBs) in 11%. During the mean 6.5 years follow-up period, 25% of the veterans experienced a cardiovascular event. Among veterans who had not been diagnosed with heart disease at the beginning of the study, the risk of developing heart disease, heart failure or stroke for the first time was 90% higher among those taking beta-blockers compared to the veterans who were taking ACEi/ARBs, the most frequently prescribed type of high blood pressure medication. The increased risk was present whether or not blood pressure was under control. Thiazide diuretics and CCBs did not increase risk. Among veterans with HIV who did not have chronic kidney disease, the use of ACEi/ARBs was associated with a lower risk of developing heart failure, compared to those patients taking other medications who were found to have about a 50% higher risk of heart failure. "Blood pressure and heart disease risk in patients who have HIV can be safely managed with first-line treatment of hypertension with ACEis, ARBs, CCBs and thiazide diuretics and may have added benefit from initial treatment with ACEis and ARBs," Cohen said.

Although CCBs are among the medications recommended for the initial treatment of hypertension, in this study beta-blockers were prescribed more frequently than CCBs.

"We were surprised by the high rates of beta-blockers prescribed for first-line hypertension treatment since they are not recommended as first-line agents," Cohen said. "We suspect this may be due to the fact that many people with HIV receive primary care from their infectious disease team, who do an amazing job at managing HIV but may not be focused on blood pressure treatment guidelines and contraindications. Ideally, a patient's primary care and infectious disease team should work together for the best possible outcomes."

Cohen said the results also highlight that there is possible harm from sing beta-blockers as first-line treatment for hypertension whether a person has HIV or not.

"While many people are appropriately treated with beta-blockers for various reasons, if you think you are taking them only for hypertension and aren't on any other blood pressure medications, I'd recommend talking to your doctor to make sure it's the best medication for you," she said.

As a retrospective analysis, the study cannot establish a cause-and-effect relationship between medication choice and heart disease events. The study results may also be affected by factors the researchers were unable to measure, such as some sociodemographic factors and patient preferences in medication choice. Although the results were the same in men and women in the study, the large proportion of men in the sample limits the ability to generalize the findings to women. Results from this study of veterans receiving care through the Veterans Health Administration also may not be generalizable to non-veterans or people who do not have health insurance or access to routine medical care.

"Patients with HIV need heightened attention to their elevated risk of heart disease. More dedicated research studying the unique needs for people with HIV and those taking ARTs is needed in order to optimize cardiovascular prevention," Cohen said.

INFORMATION:

Co-authors are Leah B. Rethy, M.D.; Matthew J. Feinstein, M.D., M.Sc.; Chad J. Achenbach, M.D., M.P.H.; Raymond R. Townsend, M.D.; Adam P. Bress, Pharm.D., M.S.; and Sanjiv J. Shah, M.D. Author disclosures are listed in the manuscript.

The study was supported by the Sarnoff Cardiovascular Foundation and the National Institutes of Health.

Additional Resources:

Multimedia may be downloaded from the right column of the release link:
https://newsroom.heart.org/news/certain-high-blood-pressure-medications-may-alter-heart-risk-in-people-with-hiv?preview=18f312b2fec7e4b07c4ff29481cb7d72
After April 5, view the manuscript online. What's the connection between high blood pressure and HIV?
As HIV patients live longer, heart disease might be their next challenge
Characteristics, Prevention and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
People living with HIV face premature heart risk and barriers to care - AHA Statement Follow AHA/ASA news on Twitter @HeartNews
Follow news from the AHA's Hypertension journal @HyperAHA Statements and conclusions of studies published in the American Heart Association's scientific journals are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers are available here, and the Association's overall financial information is available here.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

ELSE PRESS RELEASES FROM THIS DATE:

Rise of oxygen on Earth: Initial estimates off by 100 million years

2021-04-05

New research shows the permanent rise of oxygen in our atmosphere, which set the stage for life as we know it, happened 100 million years later than previously thought. A significant rise in oxygen occurred about 2.43 billion years ago, marking the start of the Great Oxidation Episode -- a pivotal moment in Earth's history. An international research team including a UC Riverside scientist analyzed rocks from South Africa formed during this event. Findings, published this week in the journal Nature, include the discovery that oxygen fluctuated dramatically after its early appearance until it became a permanent constituent of the atmosphere much later. These ...

NIH scientists develop breath test for methylmalonic acidemia

2021-04-05

Researchers at the National Institutes of Health have developed a breath test that measures how well patients with methylmalonic acidemia (MMA) respond to receiving liver or combined liver and kidney transplantation. Researchers also used the test to assess the severity of the disease in people and help determine if they would benefit from surgical or experimental genomic therapies that target the liver. The study results were published in Genetics in Medicine. Scientists at the National Human Genome Research Institute (NHGRI) led the project team, with collaborators from the National ...

Long wait times increase for children seeking emergency care for mental health

2021-04-05

Rates of prolonged visits for pediatric mental health emergency department (ED) visits increased over a decade, in contrast to non-mental health visits for which visit times remained stable, according to a study published in the journal Pediatrics. From 2005-2015, rates of ED visits lasting over six hours for children presenting for mental health issues jumped from 16 percent to nearly 25 percent, while rates of visits lasting over 12 hours increased from 5 percent to nearly 13 percent. "The trend of increasingly long ED visits for pediatric mental health problems likely represents worsening access to essential mental health services. This is concerning, especially since during the COVID-19 pandemic we are seeing substantially more children coming ...

New paper shows benefits of Louisiana coastal restoration to soil carbon sequestration

2021-04-05

BATON ROUGE, La. (March 2021) - Without restoration efforts in coastal Louisiana, marshes in the state could lose half of their current ability to store carbon in the soil over a period of 50 years, according to a new paper published in American Geophysical Union Journal of Geophysical Research Biogeosciences. "This reduction in capacity could significantly alter the global carbon budget, given that Louisiana's marsh soils account for between 5 and 21 percent of the global soil carbon storage in tidally influenced wetlands," said Melissa Baustian, lead author and coastal ecologist at The Water Institute of the Gulf. The article, "Long-term carbon sinks in marsh soils of coastal Louisiana are at risk to wetland loss" ...

New study ties solar variability to the onset of decadal La Nina events

2021-04-05

A new study shows a correlation between the end of solar cycles and a switch from El Nino to La Nina conditions in the Pacific Ocean, suggesting that solar variability can drive seasonal weather variability on Earth. If the connection outlined in the journal Earth and Space Science holds up, it could significantly improve the predictability of the largest El Nino and La Nina events, which have a number of seasonal climate effects over land. For example, the southern United States tends to be warmer and drier during a La Nina, while the northern U.S. tends to be colder ...

Outside factors may help children develop internal control

2021-04-05

PULLMAN, Wash. - The ability to control your own behavior, known as executive function, might not exist all in your head. A new theory proposes that it develops with many influences from outside the mind. The theory, detailed in Perspectives on Psychological Science, draws on dynamic systems theory which originated in mathematics and physics and has been used to describe complex organizing phenomena like cloud formation and flying patterns of birds. Now, a research team led by Washington State University human development assistant professor Sammy Perone is applying ...

Less sugar, please! New studies show low glucose levels might assist muscle repair

2021-04-03

Tokyo, Japan - Researchers from Tokyo Metropolitan University have shown that skeletal muscle satellite cells, key players in muscle repair, proliferate better in low glucose environments. This is contrary to conventional wisdom that says mammalian cells fare better when there is more sugar to fuel their activities. Because ultra-low glucose environments do not allow other cell types to proliferate, the team could produce pure cultures of satellite cells, potentially a significant boost for biomedical research. Healthy muscles are an important part of a healthy life. With the wear and tear of everyday use, our muscles continuously repair themselves to keep them in top condition. In recent years, scientists have begun to understand how muscle repair ...

Tracking receptor proteins can unveil molecular basis of memory and learning

2021-04-03

The neurons in our nervous system "talk" to each other by sending and receiving chemical messages called neurotransmitters. This communication is facilitated by cell membrane proteins called receptors, which pick up neurotransmitters and relay them across cells. In a recent study published in Nature Communications, scientists from Japan report their findings on the dynamics of receptors, which can enable understanding of the processes of memory formation and learning. The regulation of receptor movement and localization within the neuron is important for synaptic plasticity, an important process in the central nervous system. A specific type of ...

Deprivation is 'driving' Covid-19 ethnic disparities, claims new analysis

2021-04-03

DEPRIVATION among society at large is 'driving' Covid-19 disparities among minority ethnic groups - predominantly South Asian and Black African or Caribbean populations - and could be considered the main cause of disproportionate infection rates, hospitalisation and deaths experienced by these populations, according to new analysis from the University of Leicester. The study, supported by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC) comes a day after a government-commissioned review concluded race and racism have become less important factors in explaining social disparities in the UK. Researchers at the University of Leicester used UK Biobank data of 407,830 South Asian, Black ...

Prioritizing who gets vaccinated for COVID-19 saves lives

2021-04-03

Waiting for your turn can be frustrating, especially when it comes to COVID-19 vaccinations. But prioritizing who receives the limited supply of vaccines available saves lives and reduces spread of infection, according to a study published today in the journal PNAS from the University of California, Davis. While there is mostly universal agreement that older people should be prioritized, debates are currently underway about prioritizing a variety of other groups. Still others argue against targeting at all. "Prioritization has benefits because people differ in at least two key ways -- their risk of infection and the likelihood of serious consequences from infection," said senior author ...

LAST 30 PRESS RELEASES:

AI finds undiagnosed liver disease in early stages

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski